Artemether for severe malaria: A meta-analysis of randomized clinical trials

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 597-601

  Pittler, Max H ^a   Ernst, Edzard ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; QUININE;

ANTIBIOTIC RESISTANCE; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; HYPOGLYCEMIA; INJECTION SITE; MALARIA; META ANALYSIS; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINNITUS;

EID: 0033043633     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515148     Document Type: Article

References (43)

1. 1. World Health Organization, Malaria Unit. Global malaria control. Bull WHO 1993;71:281-4.
2. 2. World Health Organization. Control of tropical diseases (CTD): malaria control. Geneva: WHO Office of Information, 1995.
3. 3. World Bank. World development report 1993: investing in health. New York: Oxford University Press, 1993.
4. 4. Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull WHO 1994; 72:429-45.
5. 5. White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
6. 6. World Health Organization. Chinese herb remedy beats multidrug-resistant malaria. Geneva: WHO Office of Information, 1994.
7. 7. World Health Organization. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84(suppl 2):1-65.
8. 8. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop 1994;56:143-56.
9. 9. Qinghaosu Antimalaria Coordinating Research Group. Antimalaria studies on qinghaosu. Chin Med J 1979;92:811-6.
10. 10. Woerdenbag HJ, Pras N, van Uden W, Wallaart TE, Beekman AC, Lugt CB. Progress in the research of artemisinin-related antimalarials: an update. Pharm World Sci 1994;16:169-80.
11. 11. Karbwang J, Na-Bangchang K, Congpuong K, Molunto P, Thanavibul A. Pharmakokinetics and bioavailibility of oral and intramuscular artemether. Eur J Clin Pharmacol 1997;52:307-10.
12. 12. Sowunmi A, Oduola AMJ. Efficacy of artemether in severe falciparum malaria in African children. Acta Trop 1996;61:57-63.
13. 13. Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 1992;23:762-7.
14. 14. Pe Than Myint, Tin Shwe, Lin Soe, Ye Htut, Win Myint. Clinical study of the treatment of cerebral malaria with artemether (qinghaosu derivative). Trans R Soc Trop Med Hyg 1989;83:72.
15. 15. Pe Than Myint, Tin Shwe. A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Trans R Soc Trop Med Hyg 1987;81:559-61.
16. 16. Pe Than Myint, Tin Shwe. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma. Southeast Asian J Trop Med Public Health 1986;17:19-22.
17. 17. Resch KL, Ernst E. Research methodologies in complementary medicine: making sure it works. In: Ernst E, ed. Complementary medicine. London: Butterworth, 1996.
18. 18. Schulz KF, Chalmers J, Hyes RJ, Altman DG. Empirical evidence of bias. JAMA 1995;273:408-12.
19. 19. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
20. 20. Salako LA, Walker O, Sowunmi A, Omokhodion SJ, Risquat Adio, Oduola AMJ. Artemether in moderately severe and cerebral malaria in Nigerian children. Trans R Soc Trop Med Hyg 1994;88:13-5.
21. 21. Hensbroek van MB, Onyiorah E, Schneider G. A comparison of the effect of artemether and quinine on survival from childhood cerebral malaria. Ann Trop Med Parasitol 1996;90:434.
22. 22. Kyaw Win, Marlar Than, Ye Thwe. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Bull WHO 1992; 70:777-82.
23. 23. Tran Tinh Hien, Day NPJ, Nguyen Hoan Phu, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996;335:76-83.
24. 24. Karbwang J, Tin T, Rimchala W, et al. Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand. Trans R Soc Trop Med Hyg 1995;89:668-71.
25. 25. Murphy S, English M, Waruiru C, et al. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 1996;90:298-301.
26. 26. Hensbroek van MB, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335: 69-75.
27. 27. Walker O, Salako LA, Omokhodion SI, Sowunmi A. An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Trans R Soc Trop Med Hyg 1993;87: 564-6.
28. 28. Danis M, Chandenier J, Doumbo O, et al. Results obtained with i.m. artemether versus i.v. quinine in the treatment of severe malaria in a multicentre study in Africa. Jpn J Trop Med Hyg 1996;24(suppl 1): 93-6.
29. 29. Karbwang J, Sukontason K, Rimchala W, et al. Preliminary report: a comparative clinical trial of artemether and quinine in severe falciparum malaria. Southeast Asian J Trop Med Public Health 1992;23:768-72.
30. 30. Murphy S, Watkins WM, Bray PG, et al. Parasite viability during treatment of severe malaria: differential effects of artemether and quinine. Am J Trop Med Hyg 1995;53:303-5.
31. 31. Taylor TE, Wills BA, Kazembe P, et al. Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet 1993; 341:661-2.
32. 32. Hoffmann SL. Artemether in severe malaria-still too many deaths. Lancet 1996;335:124-5.
33. 33. Courval JM, Hensbroek van MB, Murphy S, Taylor TE. Meta-analysis of open, randomized trials comparing artemether versus quinine for cerebral malaria in African children. Jpn J Trop Med Hyg 1996;24(suppl): 97-100.
34. 34. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998;351:47-52.
35. 35. Lau J, Ioannidis JPA, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
36. 36. Meshnick SR. The mode of action of antimalarial endoperoxides. Trans R Soc Trop Med Hyg 1994;88(suppl 1):31-2.
37. 37. Bharel S, Gulati A, Abdin MZ, Srivastava PS, Jain SK. Structure, biosynthesis and functions of artemisinin. Fitoterapia 1996;67:387-402.
38. 38. Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiological Reviews 1996;60:301-15.
39. 3H]dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1984;78:265-70.
40. 40. Maeno Y, Toyoshima T, Fujioka H, et al. Morphologic effects of artemisinin in Plasmodium falciparum. Am J Trop Med Hyg 1993;49: 485-91.
41. 41. Herman PA, Adams PA. Artemisinin enhances heme-catalyzed oxidation of lipid-membranes. Free Radic Biol Med 1997;22:1283-8.
42. 42. Cavero I, Floch A, Guillet M-C, et al. Favourable profile of artemether in safety pharmacological studies. Jpn J Trop Med Hyg 1996;24(suppl 1): 79-86.
43. 43. World Health Organization, Malaria Unit. The role of artemisinin and its derivatives in the current treatment of malaria. Report of an informal consultation. Geneva: World Health Organization, 1994.